Methyl α-D-mannopyranoside could target macrophages in anti-tuberculosis inhalation therapy[1].
[1]. Maretti E, et, al. Surface engineering of Solid Lipid Nanoparticle assemblies by methyl α-d-mannopyranoside for the active targeting to macrophages in anti-tuberculosis inhalation therapy. Int J Pharm. 2017 Aug 7; 528(1-2):440-451.
















